These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 36553544)
21. Machine learning-driven prediction of brain metastasis in lung adenocarcinoma using miRNA profile and target gene pathway analysis of an mRNA dataset. Koh YW; Han JH; Haam S; Lee HW Clin Transl Oncol; 2024 Sep; 26(9):2296-2308. PubMed ID: 38568412 [TBL] [Abstract][Full Text] [Related]
22. Individual risk prediction: Comparing random forests with Cox proportional-hazards model by a simulation study. Baralou V; Kalpourtzi N; Touloumi G Biom J; 2023 Aug; 65(6):e2100380. PubMed ID: 36169048 [TBL] [Abstract][Full Text] [Related]
23. Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles. Liu Q; Qi C; Li G; Su W Biomed Res Int; 2019; 2019():5076467. PubMed ID: 31950039 [TBL] [Abstract][Full Text] [Related]
24. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma. Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839 [TBL] [Abstract][Full Text] [Related]
25. A comparison of survival models for prediction of eight-year revision risk following total knee and hip arthroplasty. Cuthbert AR; Giles LC; Glonek G; Kalisch Ellett LM; Pratt NL BMC Med Res Methodol; 2022 Jun; 22(1):164. PubMed ID: 35668349 [TBL] [Abstract][Full Text] [Related]
26. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
27. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method. Ma B; Geng Y; Meng F; Yan G; Song F J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375 [No Abstract] [Full Text] [Related]
28. Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types. Bhowmick SS; Bhattacharjee D; Rato L Comput Biol Chem; 2020 Feb; 84():107152. PubMed ID: 31785969 [TBL] [Abstract][Full Text] [Related]
29. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas. Song YZ; Li X; Li W; Wang Z; Li K; Xie FL; Zhang F World J Gastroenterol; 2018 Jul; 24(28):3145-3154. PubMed ID: 30065560 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the coverage and depth of transcriptome by RNA-Seq in chickens. Wang Y; Ghaffari N; Johnson CD; Braga-Neto UM; Wang H; Chen R; Zhou H BMC Bioinformatics; 2011 Oct; 12 Suppl 10(Suppl 10):S5. PubMed ID: 22165852 [TBL] [Abstract][Full Text] [Related]
31. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma. Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516 [TBL] [Abstract][Full Text] [Related]
32. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing. Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600 [TBL] [Abstract][Full Text] [Related]
33. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis. Zhang S; Zeng X; Lin S; Liang M; Huang H J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053 [TBL] [Abstract][Full Text] [Related]
34. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients. Deng B; Sun Z; Jason W; Yang P Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007 [TBL] [Abstract][Full Text] [Related]
35. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques. He D; Tang H; Yang X; Liu X; Zhang Y; Shi J Front Immunol; 2023; 14():1278496. PubMed ID: 37965333 [TBL] [Abstract][Full Text] [Related]
36. A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma. Liu R; Liu Y; Zhang F; Wei J; Wu L Front Immunol; 2023; 14():1146411. PubMed ID: 37063920 [TBL] [Abstract][Full Text] [Related]
37. Survival prediction models since liver transplantation - comparisons between Cox models and machine learning techniques. Kantidakis G; Putter H; Lancia C; Boer J; Braat AE; Fiocco M BMC Med Res Methodol; 2020 Nov; 20(1):277. PubMed ID: 33198650 [TBL] [Abstract][Full Text] [Related]
38. CBS-miRSeq: A comprehensive tool for accurate and extensive analyses of microRNA-sequencing data. Kesharwani RK; Chiesa M; Bellazzi R; Colombo GI Comput Biol Med; 2019 Jul; 110():234-243. PubMed ID: 31207557 [TBL] [Abstract][Full Text] [Related]
39. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis. Xiong J; Xiong K; Bing Z Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853 [TBL] [Abstract][Full Text] [Related]